BROADWOOD CAPITAL INC
Follow13F filer, CIK 1278387, New York, NY
BROADWOOD CAPITAL INC reported $1,557,326,039 across 6 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0000919574-26-007820
- Period
- 2026-09-30
- Reported value
- $1.56B
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group BROADWOOD CAPITAL INC
How groups are builtLargest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MNSTadded | +8,107,172 | $337M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0000919574-26-007820, largest first. % of portfolio is the value over $1,557,326,039, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MNSTMONSTER BEVERAGE CORP NEW | 16,214,968 | $675M | 43.33% | +8,107,172 | Timeline | ||
| STAASTAAR SURGICAL CO | 16,123,842 | $365M | 23.41% | 0 | Timeline | ||
| AXONAXON ENTERPRISE INC | 693,504 | $293M | 18.82% | 0 | Timeline | ||
| IWMISHARES TR | 474,920 | $132M | 8.47% | 0 | Timeline | ||
| LCTXLINEAGE CELL THERAPEUTICS IN | 49,560,992 | $47.4M | 3.04% | 0 | 2026-11-17, Form 4: bought 1,000,000 shares on 2026-11-17 | Timeline | |
| IMDXINSIGHT MOLECULAR DIA INC | 12,684,884 | $45.5M | 2.92% | 0 | 2026-11-17, Form 4: bought 3,428,571 shares on 2026-11-17 | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-26-007820 | base | 2026-11-16 |